Gene deletions correlate with the development of alloantibodies in von Willebrand disease.
about
von Willebrand disease: clinical and laboratory lessons learned from the large von Willebrand disease studiesThe molecular characterization of von Willebrand disease: good in partsThe molecular defect in type IIB von Willebrand disease. Identification of four potential missense mutations within the putative GpIb binding domainMolecular basis of von Willebrand disease type IIB. Candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein Ib binding sequencesDifferent regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt lymphoma.Homozygous and heterozygous deletions of the von Willebrand factor gene in patients and carriers of severe von Willebrand disease.Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA.Third Åland islands conference on von Willebrand disease, 26-28 September 2012: meeting report.The molecular biology of von Willebrand disease.Assessment of the olfactory function in Italian patients with type 3 von Willebrand disease caused by a homozygous 253 Kb deletion involving VWF and TMEM16B/ANO2Germ-line mosaicism for a valine-to-methionine substitution at residue 553 in the glycoprotein Ib-binding domain of von Willebrand factor, causing type IIB von Willebrand diseaseNonsense mutations of the von Willebrand factor gene in patients with von Willebrand disease type III and type I.Variable content of von Willebrand factor mutant monomer drives the phenotypic variability in a family with von Willebrand diseaseManagement of inherited von Willebrand disease in 2007.Alloantibodies in von Willebrand disease.Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial.Use of recombinant factor VIIa in inherited and acquired von Willebrand disease.Severe von Willebrand disease due to a defect at the level of von Willebrand factor mRNA expression: detection by exonic PCR-restriction fragment length polymorphism analysis.The genetics of Canadian type 3 von Willebrand disease: further evidence for co-dominant inheritance of mutant alleles.Translational medicine advances in von Willebrand disease.von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy.Molecular biology of von Willebrand factor.von Willebrand factor: the complex molecular genetics of a multidomain and multifunctional protein.Current management of patients with severe von Willebrand disease type 3: a 2012 update.Molecular diagnosis of von Willebrand disease.Two additional TaqI RFLPs in von Willebrand factor gene (VWF) and pseudogeneTwo TaqI polymorphisms in the 5' region of the von Willebrand factor (vWF) gene.A Taq I polymorphism in the 5' region of the von Willebrand factor (vWF) gene.Current and Emerging Options for the Management of Inherited von Willebrand Disease.Platelet morphological changes in 2 patients with von Willebrand disease type 3 caused by large homozygous deletions of the von Willebrand factor gene.Clinical and laboratory versus molecular markers for a correct classification of von Willebrand disease.Guidelines for the diagnosis and management of von Willebrand disease in Italy.Diagnosis and management of von Willebrand disease.Twenty-one years of haemophilia.
P2860
Q26863636-BA56FAD4-4981-4A39-A1D1-B932E7B76B74Q26996413-43950FF0-2D8A-4F2E-AFE6-1314DE15C257Q28776603-CBA907D9-4D38-4240-B522-C937098FB465Q28776606-B2182E4F-B40A-435A-A66F-FA082B3842C0Q33567440-37AD70B9-63D7-455C-9E3D-1AF503242DB8Q33567446-2DC14E5A-2BF5-459C-9294-F155C149AEFCQ33857871-7950EEB5-2216-4787-B5F4-0D75079B0B40Q34185963-FC355ED6-E7F4-4670-9E47-B3EB1E1F09A5Q34421530-3404B22D-E502-4DF2-91DD-A90BF614CA0FQ35032193-56D4F9A1-4CFF-49B7-AAD2-6EA524EAFB5BQ35195297-E3D70B6D-5F41-43C3-AB04-7477CBF2E092Q35195951-308CD03B-5A50-41C3-A2DC-355129D41F90Q35836882-8E4D2BD1-2EB3-42F2-8AC6-30696BB0B32EQ36911419-3D74B61E-A1FE-460C-BF00-D5C9457D2E40Q37065692-0C323894-9815-4776-8660-85205E5F4BA2Q37077021-B7C8602F-4FB2-4F46-944D-FB67F36332A3Q37080746-AD3D47C9-E050-4BC9-8696-87B8C9C48332Q37501127-ACBC89C7-57D9-40AD-9361-1E94247721E5Q37524379-8BC4AD8A-A027-4ACE-9C27-9A4D1369A85DQ37602563-2534A603-1923-4986-9FCE-EEAE278FBDB2Q37635167-2F7F9FD0-C85D-49A2-9E2F-CA4DD3385452Q37711733-BB5955EC-33E3-4A81-84A5-6EAB593B15D3Q37903943-495D583A-8DC2-4518-9DCC-B50337D85CA7Q38020749-62B5591C-2405-4018-8F17-0DDD43F3BA2DQ39144977-AD71B3FB-074D-4411-9526-498C7DEF2288Q40449185-AFAAC9A6-02D7-423B-A10B-B1CC622D2FA7Q40539985-893978E7-A4DD-4CF4-B1A2-A24D0662A60DQ40544990-9E4E5488-1389-4F30-8239-ADFE38B43154Q41620644-D387C82F-AE19-4CEA-8384-C0BD4BC4713BQ42604686-F52D7B6B-F3FA-4931-A1F6-1971F5858269Q43137286-40134FA3-1F92-44EF-A33B-84B6C8B7E099Q44117199-81EA2E0D-7C43-4BFA-BD99-AC94133781D7Q45884955-87F7EF46-6D83-4755-A038-3F4CD0868BF0Q45886252-620A8E98-16D0-480F-B60C-94A879B95641
P2860
Gene deletions correlate with the development of alloantibodies in von Willebrand disease.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Gene deletions correlate with ...... ies in von Willebrand disease.
@en
type
label
Gene deletions correlate with ...... ies in von Willebrand disease.
@en
prefLabel
Gene deletions correlate with ...... ies in von Willebrand disease.
@en
P2093
P2860
P356
P1476
Gene deletions correlate with ...... ies in von Willebrand disease.
@en
P2093
Federici AB
Mannucci PM
Shelton-Inloes BB
P2860
P304
P356
10.1172/JCI112974
P407
P577
1987-05-01T00:00:00Z